Follow
Ferry Ossendorp
Ferry Ossendorp
Unknown affiliation
Verified email at casema.nl
Title
Cited by
Cited by
Year
Specific T helper cell requirement for optimal induction of cytotoxic T lymphocytes against major histocompatibility complex class II negative tumors
F Ossendorp, E Mengedé, M Camps, R Filius, CJM Melief
The Journal of experimental medicine 187 (5), 693-702, 1998
7381998
Decreased tumor surveillance in perforin-deficient mice.
ME van den Broek, D Kägi, F Ossendorp, R Toes, S Vamvakas, WK Lutz, ...
The Journal of experimental medicine 184 (5), 1781-1790, 1996
7321996
Vaccines for established cancer: overcoming the challenges posed by immune evasion
SH van der Burg, R Arens, F Ossendorp, T van Hall, CJM Melief
Nature Reviews Cancer 16 (4), 219-233, 2016
7052016
CD4 T cells and their role in antitumor immune responses
REM Toes, F Ossendorp, R Offringa, CJM Melief
The Journal of experimental medicine 189 (5), 753-756, 1999
6591999
Therapeutic cancer vaccines
CJM Melief, T van Hall, R Arens, F Ossendorp, SH van der Burg
The Journal of clinical investigation 125 (9), 3401-3412, 2015
6502015
Proteasome and peptidase function in MHC-class-I-mediated antigen presentation
PM Kloetzel, F Ossendorp
Current opinion in immunology 16 (1), 76-81, 2004
5222004
CTLs are targeted to kill β cells in patients with type 1 diabetes through recognition of a glucose-regulated preproinsulin epitope
A Skowera, RJ Ellis, R Varela-Calviño, S Arif, GC Huang, C Van-Krinks, ...
The Journal of clinical investigation 118 (10), 3390-3402, 2008
4542008
MHC II in dendritic cells is targeted to lysosomes or T cell‐induced exosomes via distinct multivesicular body pathways
SI Buschow, ENM Nolte‐‘t Hoen, G Van Niel, MS Pols, T Ten Broeke, ...
Traffic 10 (10), 1528-1542, 2009
4312009
Efficient identification of novel Hla-A* 0201–Presented Cytotoxic T Lymphocyte epitopes in the widely expressed tumor antigen prame by Proteasome-Mediated digestion analysis
JH Kessler, NJ Beekman, SA Bres-Vloemans, P Verdijk, PA van Veelen, ...
The Journal of experimental medicine 193 (1), 73-88, 2001
3662001
Autoreactive CD8 T cells associated with β cell destruction in type 1 diabetes
GGM Pinkse, OHM Tysma, CAM Bergen, MGD Kester, F Ossendorp, ...
Proceedings of the National Academy of Sciences 102 (51), 18425-18430, 2005
3562005
Reorganization of multivesicular bodies regulates MHC class II antigen presentation by dendritic cells
M Kleijmeer, G Ramm, D Schuurhuis, J Griffith, M Rescigno, ...
The Journal of cell biology 155 (1), 53-64, 2001
3472001
Antigen-antibody immune complexes empower dendritic cells to efficiently prime specific CD8+ CTL responses in vivo
DH Schuurhuis, A Ioan-Facsinay, B Nagelkerken, JJ van Schip, C Sedlik, ...
The Journal of Immunology 168 (5), 2240-2246, 2002
3182002
CD40-targeted dendritic cell delivery of PLGA-nanoparticle vaccines induce potent anti-tumor responses
RA Rosalia, LJ Cruz, S van Duikeren, AT Tromp, AL Silva, W Jiskoot, ...
Biomaterials 40, 88-97, 2015
2882015
Dendritic cells dictate responses to PD-L1 blockade cancer immunotherapy
M Mayoux, A Roller, V Pulko, S Sammicheli, S Chen, E Sum, C Jost, ...
Science translational medicine 12 (534), eaav7431, 2020
2772020
Expression of the serpin serine protease inhibitor 6 protects dendritic cells from cytotoxic T lymphocyte–induced apoptosis: differential modulation by T helper type 1 and type …
JP Medema, DH Schuurhuis, D Rea, J van Tongeren, J de Jong, SA Bres, ...
The Journal of experimental medicine 194 (5), 657-668, 2001
2642001
Immature Dendritic Cells Acquire Cd8+Cytotoxic T Lymphocyte Priming Capacity upon Activation by T Helper Cell–Independent or–Dependent Stimuli
DH Schuurhuis, S Laban, REM Toes, P Ricciardi-Castagnoli, ...
The Journal of experimental medicine 192 (1), 145-150, 2000
2602000
Tumor-draining lymph nodes are pivotal in PD-1/PD-L1 checkpoint therapy
MF Fransen, M Schoonderwoerd, P Knopf, MGM Camps, LJAC Hawinkels, ...
JCI insight 3 (23), 2018
2572018
Dendritic cells regulate exposure of MHC class II at their plasma membrane by oligoubiquitination
G van Niel, R Wubbolts, T Ten Broeke, SI Buschow, FA Ossendorp, ...
Immunity 25 (6), 885-894, 2006
2502006
Dendritic cells process synthetic long peptides better than whole protein, improving antigen presentation and T‐cell activation
RA Rosalia, ED Quakkelaar, A Redeker, S Khan, M Camps, JW Drijfhout, ...
European journal of immunology 43 (10), 2554-2565, 2013
2372013
Strategies for immunotherapy of cancer
CJM Melief, REM Toes, JP Medema, SH Van Der Burg, F Ossendorp, ...
Academic Press 75, 235-282, 2000
2372000
The system can't perform the operation now. Try again later.
Articles 1–20